Seroprevalence of cytomegalovirus among pregnant women in Singapore
- PMID: 39363362
- PMCID: PMC11451239
- DOI: 10.1186/s41182-024-00634-z
Seroprevalence of cytomegalovirus among pregnant women in Singapore
Abstract
Background: Cytomegalovirus (CMV) is the most common congenital infection in pregnancy with potential long-term adverse effects on the fetus. There is limited data on CMV seroprevalence in pregnant women in Singapore, with last reported study dating back over two decades. We look at the latest CMV seroprevalence in antenatal population in Singapore.
Methods: Between January 2021 and August 2021, 385 pregnant women receiving antenatal care at Singapore General Hospital were randomly selected for CMV IgG test to be performed on their blood samples collected during the first trimester of their pregnancies. Positivity for CMV IgG represents past exposure prior to pregnancy.
Results: Overall CMV seroprevalence was 71.7% (276/385) (95% CI 067, 0.76, p value < 0.001). The trend of CMV IgG positivity increased with age, 68.3% (95% CI 0.60, 0.76, p value < 0.001) in those aged 20-29, 72.5% (95% CI 0.66, 0.78, p value < 0.001) in the 30-39 age group, and 79.0% (95% CI 0.67, 0.76, p value 0.012) in women over 40.
Conclusions: There is a declining trend in CMV seroprevalence among pregnant women in Singapore, which indicates that a substantial portion of this population faces the risk of primary maternal CMV infection during pregnancy. Emerging research suggests that prenatal treatment with valacyclovir effectively reduces the likelihood of vertical transmission. Considering this evidence, it is imperative to reevaluate the recommendations for universal maternal CMV screening during pregnancy.
Keywords: Antenatal; Cytomegalovirus; Seroprevalence; Singapore.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2023 Apr;61(4):436-444. doi: 10.1002/uog.26136. Ultrasound Obstet Gynecol. 2023. PMID: 36484439 Review.
-
New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.Ultrasound Obstet Gynecol. 2023 Jan;61(1):59-66. doi: 10.1002/uog.26039. Ultrasound Obstet Gynecol. 2023. PMID: 35900718
-
Seroprevalence of Cytomegalovirus Infection Among HIV-Infected and HIV-Uninfected Pregnant Women Attending Antenatal Clinic in Harare, Zimbabwe.Viral Immunol. 2019 Sep;32(7):289-295. doi: 10.1089/vim.2019.0024. Epub 2019 Jul 26. Viral Immunol. 2019. PMID: 31347990 Free PMC article.
-
Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania.BMC Res Notes. 2017 Sep 20;10(1):489. doi: 10.1186/s13104-017-2813-4. BMC Res Notes. 2017. PMID: 28931421 Free PMC article.
-
Diagnosis and antenatal management of congenital cytomegalovirus infection.Am J Obstet Gynecol. 2016 Jun;214(6):B5-B11. doi: 10.1016/j.ajog.2016.02.042. Epub 2016 Feb 20. Am J Obstet Gynecol. 2016. PMID: 26902990 Review.
References
-
- 5.3 Congenital cytomegalovirus (cCMV) | CDC [Internet]. https://www.cdc.gov/ncbddd/birthdefects/surveillancemanual/chapters/chap.... Accessed 2 Jun 2023.
-
- Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972–82. - PubMed
-
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–63. - PubMed
-
- Naing ZW, Scott GM, Shand A, Hamilton ST, Van Zuylen WJ, Basha J, et al. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol. 2016;56(1):9–18. 10.1111/ajo.12408. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous